Shattuck Labs
Robert M Hernandez, PhD has a strong background in clinical research, with experience in various leadership roles. Robert M most recently served as the Sr. Director of Clinical Research at Shattuck Labs since June 2019. Prior to that, they were the Sr. Director of Clinical Operations at Melinta Therapeutics (formerly Cempra Pharmaceuticals) from March 2014 to November 2018. Robert M also worked as a Sr. Project Manager at Ockham from November 2012 to March 2014. Additionally, they held the position of Director, Clinical Research at TransTech Pharma from December 2008 to October 2012. Earlier in their career, they worked as a CTM at Abraxis BioScience, a Project Manager at International HealthCare, LLC, and a CRA II at DCRI.
Robert M Hernandez, PhD obtained their Doctor of Philosophy (PhD) degree in Cell Biology and Anatomy from East Carolina University. Robert M attended the university from 1993 to 1998.
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.